B vitamins may stave off Alzheimer's disease. Read more...
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons in the brain. For the first...Show More Summary
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
People who have non-melanoma skin cancer may be less likely to develop Alzheimer's Disease. +Alzheimer's Reading Room People who have non-melanoma skin cancer may be less likely to develop Alzheimer's disease, according to research carried...Show More Summary
Last month, Broncos quarterback Peyton Manning pledged $500,000 to aid the Pat Summitt Foundation in its work to combat Alzheimer’s Disease but that wasn’t the end of his giving for 2013. Manning’s PeyBack Foundation is donating $581,000 to children’s organizations in four states close to Manning’s heart. He grew up in Louisiana, went to college…
People who have skin cancer may be less likely to develop Alzheimer's disease, according to research published this week in Neurology®. Researchers at the Albert Einstein College of Medicine in New York, followed 1,102 people who did not have dementia. Show More Summary
Failed Alzheimer's disease programs litter the pharmaceutical landscape. Is there any hope for this horrible disease? Maybe so.
Few diseases have frustrated researchers like Alzheimer's disease. First identified in 1906, the disease still has no cure and strikingly little real progress in helping patients. Is there any hope for light at the end of this long, dark tunnel? Dead endsThe history of dead ends in Alzheimer's research isn't encouraging. Show More Summary
Diverse attention is now being given to Alzheimer's, a disease that is poised to become the nightmare of the 21st century without transformative breakthroughs in care, treatment, and prevention.
There’s no positive side to developing skin cancer, but the latest research ties certain forms of the disease to a reduced risk of dementia. Researchers from the Albert Einstein College of Medicine in the Bronx, New York found that people who have skin cancer may be less likely to develop Alzheimer’s disease. Show More Summary
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.
Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder later in life. Now, studying spinal fluid samples and health data from 201 research participants at the Charles F. Show More Summary
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology(r), the medical journal of the American Academy of Neurology. The link does not apply to melanoma, a less common but more aggressive type of skin cancer.
Using long-term patient data, scientists have found that many of the biomarkers for Alzheimer’s identified in recent years can help accurately predict the start of full-blown disease years in advance.
Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder later in life. Now, studying spinal fluid samples and health data from 201 research participants at the Charles F. Show More Summary
Lesbian author Sarah Leavitt's new graphic novel, Tangles, looks at the impact of slowing losing a loved one to the disease. read more
A new drug reported by researchers has the potential to slow Alzheimer’s disease and reverse memory symptoms. The drug affects multiple cell signalling pathways in the brain, including a growth factor, that may cause the beneficial effects. A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits... [Continue Reading]
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, published May 14 in the journal Alzheimer's Research and Therapy, may pave the way to a new treatment for Alzheimer's disease in humans.
A drug known as J147 reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings may pave the way to a new treatment for Alzheimer's disease in humans.
A novel drug candidate, J147, is able to reverse memory deficits and improve several aspects of brain function in mice with advanced symptoms of Alzheimer's disease (AD), finds research in BioMed Central's open access journal Alzheimer's Research & Therapy. read more